These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17250661)

  • 1. Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC.
    Stella A; Surdo NC; Lastella P; Barana D; Oliani C; Tibiletti MG; Viel A; Natale C; Piepoli A; Marra G; Guanti G
    Clin Genet; 2007 Feb; 71(2):130-9. PubMed ID: 17250661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of new founder Alu-mediated rearrangements in MSH2 gene associated with a Lynch syndrome phenotype.
    Pérez-Cabornero L; Borrás Flores E; Infante Sanz M; Velasco Sampedro E; Acedo Becares A; Lastra Aras E; Cuevas González J; Pineda Riu M; Ramón y Cajal Asensio T; Capellá Munar G; Miner Pino C; Durán Domínguez M
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1546-55. PubMed ID: 21778331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer.
    Froggatt NJ; Green J; Brassett C; Evans DG; Bishop DT; Kolodner R; Maher ER
    J Med Genet; 1999 Feb; 36(2):97-102. PubMed ID: 10051005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary nonpolyposis colorectal cancer: pitfalls in deletion screening in MSH2 and MLH1 genes.
    Wehner M; Mangold E; Sengteller M; Friedrichs N; Aretz S; Friedl W; Propping P; Pagenstecher C
    Eur J Hum Genet; 2005 Aug; 13(8):983-6. PubMed ID: 15870828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel missense MSH2 gene mutation in a patient of a Korean family with hereditary nonpolyposis colorectal cancer.
    Park SJ; Lee KA; Park TS; Kim NK; Song J; Kim BY; Choi JR
    Cancer Genet Cytogenet; 2008 Apr; 182(2):136-9. PubMed ID: 18406877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.
    Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S
    Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origins and prevalence of the American Founder Mutation of MSH2.
    Clendenning M; Baze ME; Sun S; Walsh K; Liyanarachchi S; Fix D; Schunemann V; Comeras I; Deacon M; Lynch JF; Gong G; Thomas BC; Thibodeau SN; Lynch HT; Hampel H; de la Chapelle A
    Cancer Res; 2008 Apr; 68(7):2145-53. PubMed ID: 18381419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presymptomatic diagnosis using a deletion of a single codon in families with hereditary non-polyposis colorectal cancer.
    Ripa RS; Katballe N; Wikman FP; Jäger AC; Bernstein I; Orntoft T; Schwartz M; Nielsen FC; Bisgaard ML
    Mutat Res; 2005 Feb; 570(1):89-96. PubMed ID: 15680406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcoma.
    Hirata K; Kanemitsu S; Nakayama Y; Nagata N; Itoh H; Ohnishi H; Ishikawa H; Furukawa Y;
    Am J Gastroenterol; 2006 Jan; 101(1):193-6. PubMed ID: 16405554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5' region of the MSH2 gene involved in hereditary non-polyposis colorectal cancer contains a high density of recombinogenic sequences.
    Charbonnier F; Baert-Desurmont S; Liang P; Di Fiore F; Martin C; Frerot S; Olschwang S; Wang Q; Buisine MP; Gilbert B; Nilbert M; Lindblom A; Frebourg T
    Hum Mutat; 2005 Sep; 26(3):255-61. PubMed ID: 16086322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency of Muir-Torre syndrome among Lynch syndrome families.
    South CD; Hampel H; Comeras I; Westman JA; Frankel WL; de la Chapelle A
    J Natl Cancer Inst; 2008 Feb; 100(4):277-81. PubMed ID: 18270343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New founding mutation in MSH2 associated with hereditary nonpolyposis colorectal cancer syndrome on the Island of Tenerife.
    Medina-Arana V; Barrios Y; Fernández-Peralta A; Herrera M; Chinea N; Lorenzo N; Jiménez A; Martín-López JV; González-Hermoso F; Salido E; González-Aguilera JJ
    Cancer Lett; 2006 Dec; 244(2):268-73. PubMed ID: 16500024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion.
    Pastrello C; Baglioni S; Tibiletti MG; Papi L; Fornasarig M; Morabito A; Agostini M; Genuardi M; Viel A
    Eur J Hum Genet; 2006 Jan; 14(1):63-8. PubMed ID: 16251890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene.
    Banville N; Geraghty R; Fox E; Leahy DT; Green A; Keegan D; Geoghegan J; O'Donoghue D; Hyland J; Sheahan K
    Hum Pathol; 2006 Nov; 37(11):1498-502. PubMed ID: 16996571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypes.
    Huang RL; Chao CF; Ding DC; Yu CP; Chang CC; Lai HC; Yu MH; Liu HS; Chu TY
    Cancer Genet Cytogenet; 2004 Sep; 153(2):108-14. PubMed ID: 15350299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel germline hMSH2 genomic deletion and somatic hMSH2 mutations in a hereditary nonpolyposis colorectal cancer family.
    Miyaki M; Iijima T; Yamaguchi T; Shirahama S; Ito T; Yasuno M; Mori T
    Mutat Res; 2004 Apr; 548(1-2):19-25. PubMed ID: 15063132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 10-Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North-American kindred.
    Wagner A; van der Klift H; Franken P; Wijnen J; Breukel C; Bezrookove V; Smits R; Kinarsky Y; Barrows A; Franklin B; Lynch J; Lynch H; Fodde R
    Genes Chromosomes Cancer; 2002 Sep; 35(1):49-57. PubMed ID: 12203789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Founder effect of a pathogenic MSH2 mutation identified in Spanish families with Lynch syndrome.
    Menéndez M; Castellví-Bel S; Pineda M; de Cid R; Muñoz J; González S; Teulé A; Balaguer F; Ramón y Cajal T; Reñé JM; Blanco I; Castells A; Capellà G
    Clin Genet; 2010 Aug; 78(2):186-90. PubMed ID: 20095990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report on de-novo mutation in the MSH2 gene as a rare event in hereditary nonpolyposis colorectal cancer.
    Morak M; Laner A; Scholz M; Madorf T; Holinski-Feder E
    Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1101-5. PubMed ID: 19047842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A636P is associated with early-onset colon cancer in Ashkenazi Jews.
    Guillem JG; Rapaport BS; Kirchhoff T; Kolachana P; Nafa K; Glogowski E; Finch R; Huang H; Foulkes WD; Markowitz A; Ellis NA; Offit K
    J Am Coll Surg; 2003 Feb; 196(2):222-5. PubMed ID: 12595050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.